BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 17464337)

  • 1. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
    Polkinghorn WR; Tarbell NJ
    Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
    Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
    J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medulloblastoma: what is the role of molecular genetics?
    Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medulloblastoma: presentation, diagnosis and management.
    Packer RJ; Finlay JL
    Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the prognostic factors in medulloblastoma of children and adults.
    Brandes AA; Paris MK
    Crit Rev Oncol Hematol; 2004 May; 50(2):121-8. PubMed ID: 15157661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials.
    Pizer BL; Clifford SC
    Br J Neurosurg; 2009 Aug; 23(4):364-75. PubMed ID: 19637007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines.
    Holthouse DJ; Dallas PB; Ford J; Fabian V; Murch AR; Watson M; Wong G; Bertram C; Egli S; Baker DL; Kees UR
    Neuropathology; 2009 Aug; 29(4):398-409. PubMed ID: 19077040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of prognosis in children with medulloblastoma by using immunohistochemical analysis and tissue microarray.
    Shim KW; Joo SY; Kim SH; Choi JU; Kim DS
    J Neurosurg Pediatr; 2008 Mar; 1(3):196-205. PubMed ID: 18352763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medulloblastoma.
    Dhall G
    J Child Neurol; 2009 Nov; 24(11):1418-30. PubMed ID: 19841429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood medulloblastoma.
    Walker RW; Rosenblum MK
    Rev Neurol (Paris); 1992; 148(6-7):467-76. PubMed ID: 1448667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medulloblastomas: update on a heterogeneous disease.
    Bourdeaut F; Miquel C; Alapetite C; Roujeau T; Doz F
    Curr Opin Oncol; 2011 Nov; 23(6):630-7. PubMed ID: 21892087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of medulloblastoma: clues for novel therapies.
    Onvani S; Etame AB; Smith CA; Rutka JT
    Expert Rev Neurother; 2010 May; 10(5):811-23. PubMed ID: 20420498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medulloblastomas.
    Sutton LN; Packer RJ; Schut L
    Neurosurg Clin N Am; 1990 Jan; 1(1):97-109. PubMed ID: 2135976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of medulloblastoma in adults.
    Eisenstat DD
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):795-802. PubMed ID: 15485314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic risk stratification of medulloblastoma: the real time is now.
    Fisher PG; Burger PC; Eberhart CG
    J Clin Oncol; 2004 Mar; 22(6):971-4. PubMed ID: 14970187
    [No Abstract]   [Full Text] [Related]  

  • 16. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
    Lo KC; Ma C; Bundy BN; Pomeroy SL; Eberhart CG; Cowell JK
    Clin Cancer Res; 2007 Dec; 13(23):7022-8. PubMed ID: 18056178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel density and vascular endothelial growth factor expression as predictors of childrens' survival from cerebellar medulloblastoma.
    Tural S; Gercek A; Konya D; Ozgen S; Toplamoglu H; Ozek MM
    J Clin Neurosci; 2009 Sep; 16(9):1199-202. PubMed ID: 19524442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor biology and molecular characteristics of medulloblastoma identifying prognostic factors associated with survival outcomes and prognosis.
    Kim W; Choy W; Dye J; Nagasawa D; Safaee M; Fong B; Yang I
    J Clin Neurosci; 2011 Jul; 18(7):886-90. PubMed ID: 21640908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medulloblastoma: towards new prognostic factors].
    San-Galli F; Maire JP; Guérin J
    Neurochirurgie; 1991; 37(1):3-11. PubMed ID: 2017290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-adapted chemotherapy in childhood medulloblastoma.
    Varan A
    Expert Rev Anticancer Ther; 2011 May; 11(5):771-80. PubMed ID: 21554052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.